ARCELLX, INC.
Clinical trial NCT05457010 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-11-17 → 2026-10-01 3. primary completion date: 2025-09-30 → 2026-10-01
Clinical trial NCT05457010 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-11-17 → 2026-10-01 3. primary completion date: 2025-09-30 → 2026-10-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical